Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Transfusion|October 15, 2017
Funding blood safety in the 21st centuryLuke Ifland, Evan M Bloch, John P PitmanTransfusion|July 23, 2017
How do we manage blood donors and recipients after a positive Zika screening result?Alexandra Jimenez, Beth H Shaz, Debra Kessler, et al.Transfusion|November 11, 2021
Powassan virus: What is the risk to the blood supply?Evan M Bloch, Aaron A R Tobian, Louis M KatzTransfusion|August 12, 2014
Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supplyAlex J Goodell, Evan M Bloch, Peter J Krause, et al.Transfusion|September 25, 2016
The contribution of unsafe blood transfusion to human immunodeficiency virus incidence in sub-Saharan Africa: reexamination of the 5% to 10% conventionMalika M Morar, John P Pitman, Willi McFarland, et al.Transfusion|June 28, 2017
Medical and economic implications of strategies to prevent alloimmunization in sickle cell diseaseEric A Gehrie, Paul M Ness, Evan M Bloch, et al.Transfusion|October 17, 2012
A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United StatesSteven Kleinman, William Reed, Adonis StassinopoulosTransfusion|December 16, 2011
The third described case of transfusion-transmitted Babesia duncaniEvan M Bloch, Barbara L Herwaldt, David A Leiby, et al.Transfusion|November 6, 2024
Longitudinal outcomes of chronically transfused adults with sickle cell disease and a history of childhood strokeJennifer M Jones, Julia Wool, Elizabeth P Crowe, et al.Transfusion|October 29, 2015
A retrospective analysis of false-positive infectious screening results in blood donorsMichelle T Vo, Roberta Bruhn, Zhanna Kaidarova, et al.Pageof 7